v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 250,671 $ 119,077
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 219,001 205,068
Deferred income taxes 60,918 21,693
Share-based compensation 45,179 30,450
Non-cash rent expense 28,876 25,181
Impairment charges associated with long-lived assets 1,293 2,941
Loss (gain) on disposal of property and equipment, net 4,953 (6,548)
Write-off of debt discounts and issuance costs 0 3,510
Amortization of debt discounts and issuance costs 2,729 5,891
Changes in operating assets and liabilities 18,576 1,794
Other (1,530) 2,919
Net cash provided by operating activities 630,666 411,976
Cash flows from investing activities:    
Capital expenditures (586,980) (388,213)
Proceeds from sale-leaseback transactions 172,683 207,714
Proceeds from the sale of land 0 15,577
Other (21,786) 2,819
Net cash used in investing activities (436,083) (162,103)
Cash flows from financing activities:    
Repayments of debt (14,292) (408,612)
Proceeds from revolving credit facility 220,000 1,045,000
Repayments of revolving credit facility (230,000) (925,000)
Repayments of finance lease liabilities (1,604) (626)
Proceeds from financing obligations 10,300 4,300
Payments of debt discounts and issuance costs (628) (1,873)
Proceeds from the issuance of common stock, net of issuance costs 0 124,357
Proceeds from stock option exercises 37,616 19,548
Proceeds from issuances of common stock in connection with the employee stock purchase plan 1,875 1,462
Other (4,341) (1,304)
Net cash provided by (used in) financing activities 18,926 (142,748)
Effect of exchange rates on cash and cash equivalents and restricted cash and cash equivalents 51 (38)
Increase in cash and cash equivalents and restricted cash and cash equivalents 213,560 107,087
Cash and cash equivalents and restricted cash and cash equivalents – beginning of period 27,878 29,966
Cash and cash equivalents and restricted cash and cash equivalents – end of period $ 241,438 $ 137,053